Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
266M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
48.5M
-
Shares change
-
-2.75M
-
Total reported value, excl. options
-
$721M
-
Value change
-
-$164M
-
Put/Call ratio
-
4.26
-
Number of buys
-
91
-
Number of sells
-
-70
-
Price
-
$14.86
Significant Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q2 2022
189 filings reported holding OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2022.
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.5M shares
of 266M outstanding shares and own 18.24% of the company stock.
Largest 10 shareholders include FMR LLC (7.17M shares), JPMORGAN CHASE & CO (5.19M shares), VANGUARD GROUP INC (4.34M shares), BlackRock Inc. (3.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.85M shares), Bellevue Group AG (2.33M shares), Champlain Investment Partners, LLC (1.67M shares), Allspring Global Investments Holdings, LLC (1.49M shares), STATE STREET CORP (1.16M shares), and WASATCH ADVISORS INC (1.15M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.